ahc 52 has been researched along with triazoles in 1 studies
Studies (ahc 52) | Trials (ahc 52) | Recent Studies (post-2010) (ahc 52) | Studies (triazoles) | Trials (triazoles) | Recent Studies (post-2010) (triazoles) |
---|---|---|---|---|---|
7 | 0 | 0 | 25,808 | 2,252 | 13,501 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbracchio, MP; Jacobson, KA; Jiang, JL; Kim, YC; Sei, Y; Yao, Y | 1 |
1 other study(ies) available for ahc 52 and triazoles
Article | Year |
---|---|
Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists.
Topics: Adenosine; Apoptosis; Dihydropyridines; DNA Fragmentation; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Quinazolines; Triazoles | 1997 |